Drug Profile
U 88999
Alternative Names: U 88Latest Information Update: 03 Sep 1998
Price :
$50
*
At a glance
- Originator Unknown
- Developer Pharmacia Corporation
- Class Antiarrhythmics
- Mechanism of Action Antioxidants; Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias
Most Recent Events
- 03 Sep 1998 No-Development-Reported for Arrhythmias in Japan (Unknown route)
- 12 Nov 1996 New profile
- 12 Nov 1996 Preclinical development for Arrhythmias in Japan (Unknown route)